NASDAQ:TRHC - Nasdaq - US8733791011 - Common Stock - Currency: USD
NASDAQ:TRHC (11/2/2023, 8:12:48 PM)
10.5
+0.09 (+0.86%)
The current stock price of TRHC is 10.5 USD. In the past month the price increased by 1.16%. In the past year, price increased by 203.47%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
VEEV | VEEVA SYSTEMS INC-CLASS A | 36.13 | 36.66B | ||
DOCS | DOXIMITY INC-CLASS A | 56.54 | 13.58B | ||
WAY | WAYSTAR HOLDING CORP | N/A | 7.26B | ||
CERT | CERTARA INC | 33.77 | 2.12B | ||
TDOC | TELADOC HEALTH INC | N/A | 1.98B | ||
GDRX | GOODRX HOLDINGS INC-CLASS A | 15.03 | 1.83B | ||
SDGR | SCHRODINGER INC | N/A | 1.65B | ||
PHR | PHREESIA INC | N/A | 1.64B | ||
EVH | EVOLENT HEALTH INC - A | 15.8 | 1.22B | ||
HSTM | HEALTHSTREAM INC | 50.58 | 999.88M | ||
LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 966.46M | ||
DH | DEFINITIVE HEALTHCARE CORP | 14.47 | 762.50M |
Tabula Rasa Healthcare, Inc. is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. The company is headquartered in Moorestown, New Jersey and currently employs 1,027 full-time employees. The company went IPO on 2016-09-29. The firm operates through two segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides its clients, primarily organizations with programs of All-Inclusive Care for the Elderly (PACE), with medication fulfillment services, cloud-based software, pharmacy benefit management (PBM) solutions, and clinical pharmacist services at the point-of-care. PACE is a Centers for Medicare & Medicaid Services (CMS) sponsored program. The MedWise HealthCare segment provides technology-enabled solutions to promote medication safety and adherence to improve patient outcomes and reduce healthcare costs. The technology-enabled solutions revenue model is primarily based on payments on a PMPM basis, payments on a subscription basis, and payments on a fee-for-service basis for each medication safety review and clinical assessment completed.
TABULA RASA HEALTHCARE INC
228 Strawbridge Drive
Moorestown NEW JERSEY 08057 US
CEO: Calvin H. Knowlton
Employees: 1027
Company Website: https://www.tabularasahealthcare.com/
Phone: 18666482767.0
The current stock price of TRHC is 10.5 USD. The price increased by 0.86% in the last trading session.
The exchange symbol of TABULA RASA HEALTHCARE INC is TRHC and it is listed on the Nasdaq exchange.
TRHC stock is listed on the Nasdaq exchange.
9 analysts have analysed TRHC and the average price target is 10.71 USD. This implies a price increase of 2% is expected in the next year compared to the current price of 10.5. Check the TABULA RASA HEALTHCARE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
TABULA RASA HEALTHCARE INC (TRHC) has a market capitalization of 284.02M USD. This makes TRHC a Micro Cap stock.
TABULA RASA HEALTHCARE INC (TRHC) currently has 1027 employees.
TABULA RASA HEALTHCARE INC (TRHC) has a support level at 10.41 and a resistance level at 10.51. Check the full technical report for a detailed analysis of TRHC support and resistance levels.
The Revenue of TABULA RASA HEALTHCARE INC (TRHC) is expected to grow by 21.88% in the next year. Check the estimates tab for more information on the TRHC EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
TRHC does not pay a dividend.
TABULA RASA HEALTHCARE INC (TRHC) will report earnings on 2024-03-04, after the market close.
TABULA RASA HEALTHCARE INC (TRHC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.3).
ChartMill assigns a technical rating of 9 / 10 to TRHC. When comparing the yearly performance of all stocks, TRHC is one of the better performing stocks in the market, outperforming 99.44% of all stocks.
ChartMill assigns a fundamental rating of 2 / 10 to TRHC. Both the profitability and financial health of TRHC have multiple concerns.
Over the last trailing twelve months TRHC reported a non-GAAP Earnings per Share(EPS) of -0.3. The EPS increased by 50% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -26.82% | ||
ROE | N/A | ||
Debt/Equity | N/A |
ChartMill assigns a Buy % Consensus number of 49% to TRHC. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 94.12% and a revenue growth 21.88% for TRHC